Tomomasa H, Oshio S, Ashizawa Y, Kamiyama Y, Okano Y, Iiyama T, Sato S, Shimizu H, Umeda T
Department of Urology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
Arch Androl. 2002 Nov-Dec;48(6):405-15. doi: 10.1080/01485010290099318.
The gonadal function of 18 patients with testicular germ cell tumors was evaluated. Seminal parameters after orchiectomy were examined in 15 patients. Six of them were available for follow-up observation after 2 or 3 courses of adjuvant chemotherapy. Serum gonadal hormones before and after orchiectomy were evaluated in 7 patients (testosterone and PRL were not examined in one patient). Five of 15 (33.3%), 8 of 15 (53.3%), 13 of 15 (86.7%), 7 of 13 (53.8%), and 9 of 12 (75.0%) had abnormal values in seminal volume, sperm concentration, motility, morphology, and vitality, respectively. The sperm concentration gradually improved after chemotherapy following orchiectomy in 5 of 6 (83.3%) patients. In all the patients examined, serum levels of follicular stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL) increased after orchiectomy. Serum levels of testosterone increased in 4 patients, but decreased in 2 after orchiectomy. These findings suggest that several factors, including preexisting intrinsic defect and disturbance of the hypothalamus-pituitary-gonadal axis, are involved in the deterioration of gonadal function in patients with testicular germ cell tumors.
对18例睾丸生殖细胞肿瘤患者的性腺功能进行了评估。对15例患者进行了睾丸切除术后的精液参数检查。其中6例在接受2或3个疗程的辅助化疗后可供随访观察。对7例患者评估了睾丸切除术前和术后的血清性腺激素(1例患者未检测睾酮和催乳素)。15例患者中,精液量、精子浓度、活力、形态和存活率异常的分别有5例(33.3%)、8例(53.3%)、13例(86.7%)、7例(53.8%)和9例(75.0%)。6例患者中有5例(83.3%)在睾丸切除术后化疗后精子浓度逐渐改善。在所有接受检查的患者中,睾丸切除术后血清促卵泡激素(FSH)、促黄体生成素(LH)和催乳素(PRL)水平均升高。4例患者睾丸切除术后血清睾酮水平升高,但2例降低。这些发现表明,包括先前存在的内在缺陷和下丘脑-垂体-性腺轴紊乱在内的多种因素参与了睾丸生殖细胞肿瘤患者性腺功能的恶化。